WO1993019178A3 - Peptides utilises pour l'induction de tolerance - Google Patents
Peptides utilises pour l'induction de tolerance Download PDFInfo
- Publication number
- WO1993019178A3 WO1993019178A3 PCT/US1993/002462 US9302462W WO9319178A3 WO 1993019178 A3 WO1993019178 A3 WO 1993019178A3 US 9302462 W US9302462 W US 9302462W WO 9319178 A3 WO9319178 A3 WO 9319178A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- peptide
- seq
- peptides
- inducing tolerance
- peptides useful
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Toxicology (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Physiology (AREA)
- Food Science & Technology (AREA)
- Plant Pathology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Pulmonology (AREA)
- Cell Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5516715A JPH07505365A (ja) | 1992-03-25 | 1993-03-25 | 耐性の誘導に有用なペプチド |
AU39226/93A AU677954B2 (en) | 1992-03-25 | 1993-03-25 | Peptides useful for inducing tolerance |
CA2132873A CA2132873C (fr) | 1992-03-25 | 1993-03-25 | Peptides pouvant induire la tolerance |
EP93908385A EP0672134A1 (fr) | 1992-03-25 | 1993-03-25 | Peptides utilises pour l'induction de tolerance |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US85731192A | 1992-03-25 | 1992-03-25 | |
US07/857,311 | 1992-03-25 | ||
US88471892A | 1992-05-15 | 1992-05-15 | |
US07/884,718 | 1992-05-15 | ||
US611693A | 1993-01-15 | 1993-01-15 | |
US08/006,116 | 1993-01-15 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1993019178A2 WO1993019178A2 (fr) | 1993-09-30 |
WO1993019178A3 true WO1993019178A3 (fr) | 1993-11-25 |
Family
ID=27358042
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1993/002462 WO1993019178A2 (fr) | 1992-03-25 | 1993-03-25 | Peptides utilises pour l'induction de tolerance |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0672134A1 (fr) |
JP (1) | JPH07505365A (fr) |
AU (1) | AU677954B2 (fr) |
CA (1) | CA2132873C (fr) |
IL (1) | IL105153A (fr) |
MX (1) | MX9301675A (fr) |
WO (1) | WO1993019178A2 (fr) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6120769A (en) * | 1989-11-03 | 2000-09-19 | Immulogic Pharmaceutical Corporation | Human T cell reactive feline protein (TRFP) isolated from house dust and uses therefor |
US6019972A (en) | 1989-11-03 | 2000-02-01 | Immulogic Pharmaceutical Corporation | Peptides of human T cell reactive feline protein (TRFP) |
WO1994027634A1 (fr) * | 1993-06-02 | 1994-12-08 | Institute For Child Health Research | Peptides caches permettant d'induire une tolerance immunologique |
US6759234B1 (en) * | 1994-09-02 | 2004-07-06 | Immulogic Pharmaceutical Corporation | Compositions and methods for administering to humans, peptides capable of down regulating an antigen specific immune response |
AU4278296A (en) * | 1994-10-25 | 1996-05-15 | Immulogic Pharmaceutical Corporation | Compositions and treatment for multiple sclerosis |
US6379670B1 (en) | 1994-11-18 | 2002-04-30 | Neurocrine Biosciences, Inc. | Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein |
US6251396B1 (en) | 1994-11-18 | 2001-06-26 | Neurocrine Biosciences, Inc. | Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein |
JP4340329B2 (ja) * | 1996-03-21 | 2009-10-07 | サーカッシア リミテッド | 潜在ペプチドならびにそれらの同定方法 |
EP0960887B1 (fr) | 1996-06-14 | 2007-04-25 | Meiji Dairies Corporation | Peptides constitues d'epitopes de lymphocytes t |
US6780416B1 (en) | 2000-02-18 | 2004-08-24 | Ecole Polytechnique Federale De Lausanne | Bee venom polypeptides and methods of use thereof |
US7923209B2 (en) | 2003-03-14 | 2011-04-12 | Anergis, S.A. | Allergen peptide fragments and use thereof |
AT503690A1 (de) * | 2006-06-09 | 2007-12-15 | Biomay Ag | Hypoallergene moleküle |
CA2744787C (fr) | 2008-11-30 | 2019-06-11 | Immusant, Inc. | Compositions et procedes pour le traitement d'une maladie coeliaque |
US10449228B2 (en) | 2013-09-10 | 2019-10-22 | Immusant, Inc. | Dosage of a gluten peptide composition |
AU2015323979A1 (en) | 2014-09-29 | 2017-05-18 | Immusant, Inc. | Use of HLA genetic status to assess or select treatment of celiac disease |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991006571A1 (fr) * | 1989-11-03 | 1991-05-16 | Immulogic Pharmaceutical Corporation | Proteine de felin reagissant avec des lymphocytes t humains (pfrl), isolee a partir de poussieres menageres |
WO1992015613A1 (fr) * | 1991-02-28 | 1992-09-17 | Immulogic Pharmaceutical Corporation | Preparation amelioree d'allergenes aux phaneres de chat a des fins d'immunotherapie et utilisations de cette preparation |
WO1993008280A1 (fr) * | 1991-10-16 | 1993-04-29 | Immulogic Pharmaceutical Corporation | Peptides d'epitope recombine |
-
1993
- 1993-03-24 IL IL10515393A patent/IL105153A/en not_active IP Right Cessation
- 1993-03-25 CA CA2132873A patent/CA2132873C/fr not_active Expired - Lifetime
- 1993-03-25 MX MX9301675A patent/MX9301675A/es unknown
- 1993-03-25 WO PCT/US1993/002462 patent/WO1993019178A2/fr not_active Application Discontinuation
- 1993-03-25 EP EP93908385A patent/EP0672134A1/fr not_active Withdrawn
- 1993-03-25 AU AU39226/93A patent/AU677954B2/en not_active Expired
- 1993-03-25 JP JP5516715A patent/JPH07505365A/ja active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991006571A1 (fr) * | 1989-11-03 | 1991-05-16 | Immulogic Pharmaceutical Corporation | Proteine de felin reagissant avec des lymphocytes t humains (pfrl), isolee a partir de poussieres menageres |
WO1992015613A1 (fr) * | 1991-02-28 | 1992-09-17 | Immulogic Pharmaceutical Corporation | Preparation amelioree d'allergenes aux phaneres de chat a des fins d'immunotherapie et utilisations de cette preparation |
WO1993008280A1 (fr) * | 1991-10-16 | 1993-04-29 | Immulogic Pharmaceutical Corporation | Peptides d'epitope recombine |
Also Published As
Publication number | Publication date |
---|---|
IL105153A (en) | 1999-12-22 |
EP0672134A1 (fr) | 1995-09-20 |
AU677954B2 (en) | 1997-05-15 |
MX9301675A (es) | 1993-12-01 |
CA2132873A1 (fr) | 1993-09-30 |
WO1993019178A2 (fr) | 1993-09-30 |
CA2132873C (fr) | 2012-10-16 |
JPH07505365A (ja) | 1995-06-15 |
IL105153A0 (en) | 1993-07-08 |
AU3922693A (en) | 1993-10-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1993019178A3 (fr) | Peptides utilises pour l'induction de tolerance | |
DK0590006T3 (da) | Syntetiske pulmonære surfaktantpeptider | |
CA2169635A1 (fr) | Methode, compositions et dispositifs pour administrer des polynucleotides nus codant des peptides biologiquement actifs | |
CA2025598A1 (fr) | Proteines d'antigene nucleocapsidique d'hepadnavirus chimerique | |
ATE415173T1 (de) | Pan dr-bindeproteinen zur erhöhung der immunantwort | |
ATE368053T1 (de) | Antimikrobielle peptide | |
EP0284587A3 (fr) | Antigènes peptides synthétiques pour la détection d'infections de HIV-1 | |
AU4826493A (en) | Anti-feline immunodeficiency virus (fiv) vaccines | |
EP0334244A3 (fr) | Peptides antagonistes de Bradykinine | |
IL93397A (en) | Pancreatic islet cell antigen protein or peptides, their preparation by molecular cloning, their use in the diagnosis of insulin dependent diabetes mellitus and pharmaceutical compositions comprising said antigens | |
EP0733071A4 (fr) | Antagonistes de la chaperonine 10 | |
WO2002044197A3 (fr) | Peptides de fixation des recepteurs des cytokines | |
CA2083177A1 (fr) | Proteines surfactantes alveolaires | |
EP0161007A3 (fr) | Analogues de l'hexapeptide rétro-inverso C-terminal de la substance P | |
EP0129582A4 (fr) | Peptides et proteines biologiquement actifs pour administration orale. | |
WO1993021321A3 (fr) | EPITOPES DE LYMPHOCYTES T DES PRINCIPAUX ALLERGENES D'$i(AMBROSIA ARTEMISIIFOLIA) | |
KR960702754A (ko) | 생리적으로 활성인 펩티드를 함유하는 질내 투여 제제(vaginal preparation containing physiologically active peptide) | |
AU682638B2 (en) | Peptide, bronchodilator and blood flow ameliorant | |
CA2128407A1 (fr) | Peptides synthetiques pour vaccin antirubeoleux | |
CA2139571A1 (fr) | Peptides fixatrices du recepteur de l'interferon | |
CA2057612A1 (fr) | Peptides selectionnes de l'antigene specifique au groupe (gag) du virus de l'immunodeficience humaine (vih), sa preparation et son utilisation | |
AU4712993A (en) | New peptides, antibodies raised against peptides and means for blocking said antibodies, application as medicaments, pharmaceutical compositions and utilization methods | |
CA2163212A1 (fr) | Composes therapeutiques | |
EP0317279A3 (fr) | Peptides pour l'usage dans la purification du facteur-VIII | |
CA2163805A1 (fr) | Nouveau facteur d'activation des leucocytes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AU CA FI HU JP KP KR NO NZ PT |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AU CA FI HU JP KP KR NO NZ PT |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2132873 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1993908385 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1993908385 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1993908385 Country of ref document: EP |